Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed
MS Butler, V Gigante, H Sati, S Paulin… - Antimicrobial agents …, 2022 - Am Soc Microbiol
There is an urgent global need for new strategies and drugs to control and treat multidrug-
resistant bacterial infections. In 2017, the World Health Organization (WHO) released a list of …
resistant bacterial infections. In 2017, the World Health Organization (WHO) released a list of …
Shortage of essential antimicrobials: a major challenge to global health security
N Shafiq, AK Pandey, S Malhotra, A Holmes… - BMJ global …, 2021 - gh.bmj.com
The lack of access to safe and effective antimicrobials for human populations is a threat to
global health security and a contributor to the emergence and spread of antimicrobial …
global health security and a contributor to the emergence and spread of antimicrobial …
Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicines: Study examines global antibacterial pull incentives.
K Outterson - Health Affairs, 2021 - healthaffairs.org
Antibacterial medicines should be foundational for modern medicine—a key part of the
infrastructure of contemporary practice. Recently, however, antibacterials have struggled …
infrastructure of contemporary practice. Recently, however, antibacterials have struggled …
[PDF][PDF] Ambitious USG Advanced Commitment for Subscription-Based Purchasing of Novel Antimicrobials and Its Expected Return on Investment
A Towse, RS Bonnifield - 2022 - cgdev.org
Anti-microbial drugs form the backbone of modern medicine. Yet their lifespan is naturally
limited; over time, use of these drugs selects for mutations that survive exposure those same …
limited; over time, use of these drugs selects for mutations that survive exposure those same …
Sales Revenues for New Therapeutic Agents Approved by the United States Food and Drug Administration From 1995 to 2014
Objectives This study aimed to analyze worldwide sales of new therapeutic agents and to
estimate the time it takes for product sales to exceed industry-wide average drug …
estimate the time it takes for product sales to exceed industry-wide average drug …
New antibiotics for multi-drug resistant bacterial strains
B Moukafih, S El Marrakchi, I Bennani… - Cahiers Santé Médecine …, 2022 - jle.com
La résistance aux antimicrobiens est un problème de santé majeur. Elle augmente la
mortalité et la morbidité et met à rude épreuve les systèmes de santé. La découverte de …
mortalité et la morbidité et met à rude épreuve les systèmes de santé. La découverte de …
Les nouveaux antibiotiques pour les souches bactériennes multirésistantes.
B Moukafih, SE Marrakchi, I Bennani… - Cahiers Santé …, 2023 - search.ebscohost.com
La résistance aux antimicrobiens est un problème de santé majeur. Elle augmente la
mortalité et la morbidité et met à rude épreuve les systèmes de santé. La découverte de …
mortalité et la morbidité et met à rude épreuve les systèmes de santé. La découverte de …
Collateral selective landscape of drug resistance in experimentally evolved biofilms of Pseudomonas aeruginosa
G Wickham - 2021 - ueaeprints.uea.ac.uk
Biofilms represent a discrete form of microbial life which possess physiological distinctions
from free-living planktonic counterparts which may also elicit lifestyle-dependent adaptive …
from free-living planktonic counterparts which may also elicit lifestyle-dependent adaptive …